Publication:
Effects of captopril on the development of rat doxorubicin nephropathy

dc.contributor.authorSquadrito, F.es
dc.contributor.authorMacchiarelli, C.es
dc.contributor.authorSantoro, G.
dc.contributor.authorArcoraci, V.
dc.contributor.authorTrimarchi, G.R.
dc.contributor.authorSturniolo, R.
dc.contributor.authorNottola, S.A.
dc.contributor.authorMotta, P.M.
dc.contributor.authorCaputi, A.P.
dc.date.accessioned2011-02-01T08:46:52Z
dc.date.available2011-02-01T08:46:52Z
dc.date.issued1992
dc.description.abstractThe effects of a daily administration of an anti-converting enzyme inhibitor, Captopril (CPT) (100 mg/kg/orally), on the development of functional and morphological alterations induced in rats by a single injection (7.5 mg/kg/iv) of Doxorubicin (DXR) (Adnamycin*), were investigated. Twenty-four-hour protein excretion, urine output, food intake, water intake, and body weight gain were measured weekly for 30 days. Transmission and scanning electron microscopy observations were performed on kidney samples after 30 days. Four groups were studied. Group 1 were control rats. Group 2 were rats injected with DXR. Group 3 were rats injected with DXR and treated with CPT for 30 days. Group 4 were rats injected with DXR and treated with CPT for 15 days (CPT treatment started 15 days after DXR injection). Group 1 did not show significant functional or morphological changes. Group 2 showed severe proteinuria, significant increase in urinary volume within 2 weeks, significant body weight reduction and diffuse morphological changes. These changes mainly consisted of podocyte swelling, severe foot process fusion, and presence of casts within tubular lumen. Group 3, with respect to group 2, showed a significant reduction of the 24 h protein excretion and urine output. This group displayed morphological changes similar to those observed in group 2, but with a focal distribution. Group 4 showed functional and morphological changes comparable with those of group 2. It is concluded that CPT partially inhibits the development of the functional and morphological damage induced by DXR in the rat kidney. However, CPT did not influence the natural development of nephropathy when treatment started 15 days after DXR injection.es
dc.formatapplication/pdfes
dc.format.extent7es
dc.identifier.issn0213-3911es
dc.identifier.urihttp://hdl.handle.net/10201/18303
dc.languageenges
dc.publisherMurcia : F. Hernándezes
dc.relation.ispartofHistology and histopathologyes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectCaptopriles
dc.subjectKidneyes
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicinaes
dc.titleEffects of captopril on the development of rat doxorubicin nephropathyes
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Effects of captopril on the development of rat doxorubicin nephropathy.pdf
Size:
3.96 MB
Format:
Adobe Portable Document Format
Description: